Lucid Diagnostics Inc. Revenue 2021–2025
Lucid Diagnostics Inc. annual/quarterly revenue history and growth rate from 2021 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lucid Diagnostics Inc. revenue for the quarter ending March 31, 2026 was 1.3 M, a 51.69% increase year-over-year.
- Lucid Diagnostics Inc. revenue for the twelve months ending March 31, 2026 was 4.5 M, a 13.38% increase year-over-year.
- Lucid Diagnostics Inc. annual revenue for 2025 was 4.7 M, a 8.28% increase from 2024.
- Lucid Diagnostics Inc. annual revenue for 2024 was 4.3 M, a 79.00% increase from 2023.
- Lucid Diagnostics Inc. annual revenue for 2023 was 2.4 M, a 544.03% increase from 2022.
- Lucid Diagnostics Inc. annual revenue for 2022 was 377000.
Lucid Diagnostics Inc. (LUCD) — Frequently Asked Questions
Lucid Diagnostics Inc. (LUCD) is a publicly traded US company. It has a market capitalization of $126M. In fiscal 2025 it reported revenue of $5M and net income of -$58M. Explore LUCD's stock price, financial statements, earnings history, margins and key ratios below.
What is Lucid Diagnostics Inc.'s market cap?
Lucid Diagnostics Inc. (LUCD) has a market capitalization of $126M.
What is the LUCD stock price?
LUCD trades at $0.96 (-4.84% on the day).
How much revenue does Lucid Diagnostics Inc. make?
Lucid Diagnostics Inc. reported revenue of $5M in fiscal 2025.
Is LUCD profitable?
In fiscal 2025, Lucid Diagnostics Inc. reported net income of -$58M.